Unicorn Companies

Showing 979 articles
Business

MasTec's Growth Engine Faces a Cost Test: Can Margins Hold the Line?

Despite a stellar share price run, MasTec's earnings quality is under scrutiny as persistent margin pressures from supply chain strains and strategic growth investments challenge its financial resilience. Investors are watching to see if management can steer the infrastructure giant toward more sustainable profitability.

Business

REV Group Merges Into Terex, Shifting Investor Landscape and Strategic Focus

The completion of REV Group's merger with Terex Corporation marks a significant corporate realignment, moving the specialty vehicle manufacturer from a standalone NYSE listing to a subsidiary within a larger industrial equipment platform. This restructuring alters how investors track performance and assess exposure to key markets like emergency services and recreational vehicles.

Business

Gilead Sciences Bets on Precision Oncology to Power Next Growth Phase

Gilead Sciences, the biopharma giant known for its HIV treatments, is strategically pivoting to become a major player in cancer therapy. Through targeted licensing and a focus on precision oncology, the company aims to build a multi-billion dollar revenue stream by the end of the decade, reducing its reliance on mature franchises.